AmoyDx lung cancer multi-panel 7-gene (FF)

TOP
gene-related test
genetic tests for malignant tumor (solid tumor)
AmoyDx lung cancer multi-panel 7-gene (FF)

Laboratory：Akiruno

○AmoyDx lung cancer multi-panel 7-gene (FF)

CODE：00P66 3

TEST NAME SPECIMEN
REQUIREMENT
（ｍL） CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT)
AmoyDx lung cancer multi-panel 7-gene (FF)
tissue
100mg
ARR
4-7 PCR (real-time PCR), RT-PCR (real-time PCR)

COMMENT

The purpose of this study is to analyze BRAF V600E mutations, EGFR gene mutation, ALK fusion gene, ROS1 fusion gene, MET gene exon 14 skipping mutation, KRAS G12C gene mutation, and RET fusion gene in genomic DNA and RNA extracted from cancer tissues to determine the indications for the drugs listed in the attached table for patients with non-small cell lung cancer.
The available days are Monday to Friday.
Please make sure that the material contains the tumor site before submitting it. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.0M961 2).
●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.

CONTAINER

ARR 旧容器記号 r A

滅菌ポリスピッツ

貯蔵方法：室温

supplementary information

対象遺伝子変異等と関連する医薬品および適応がん腫

遺伝子変異等	がん腫	関連する医薬品
BRAF V600E変異	非小細胞肺癌	ダブラフェニブメシル酸塩及びトラメチニブジメチルスルホキシド付加物の併用投与
EGFR遺伝子変異		ゲフィチニブ、エルロチニブ塩酸塩、アファチニブマレイン酸塩、オシメルチニブメシル酸塩
ALK融合遺伝子		クリゾチニブ、アレクチニブ塩酸塩、ブリグチニブ
ROS1融合遺伝子		クリゾチニブ、エヌトレクチニブ
MET ex14スキッピング変異		テポチニブ塩酸塩水和物
KRAS G12C遺伝子変異		ソトラシブ
RET融合遺伝子		セルペルカチニブ

TEST DIRECTORY